Has anyone information about ND0612, a levodopa-carbidopa solution that is administered subcutaneously

[maier1959]

Does anyone have infomations, when ND0612 will be approved EU or USA. This is one of the liquid Dopa solutions which will be the next advance in therapy. There are three or four substances in the pipeline (ABBV-951 by abbevie, Infudopa SubC™ by Dizlin ), but Nd 0612 seemed to be the first one of these substances.

[Juliegrace]

They’re in phase three trials, but I think ABBV-951 might be a little further along. Not sure though. If you go to clinics trials.gov and search “subcutaneous levodopa” the current trial information is available.